Truveta brand logo mark in teal on a black background, featuring stacked chevron shapes forming the Truveta symbol.

Briefing

Advancing neurology research with Truveta

Neurologic diseases require years of follow-up to understand progression, treatment effectiveness, and outcomes. Yet many real-world datasets lack the clinical detail needed to study the full patient journey. Truveta combines longitudinal EHR data with neuroimaging, clinical notes, patient-reported outcomes, and linked claims and mortality data to help researchers characterize patient populations, evaluate treatments, and generate evidence across the product lifecycle.

Download the briefing to explore:

  • How deep clinical phenotypes support more precise neurologic patient populations.
  • How longitudinal data enables research on disease progression and outcomes.
  • How Truveta captures the neurologic patient journey across diverse care settings, helping researchers generate more complete real-world evidence.
  • How linked neuroimaging and clinical data support biomarker discovery and AI development.

Read the briefing now